Skip to main content
logo
Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
10.94
+0.33 (3.11%)
Feb 2, 2026, 4:00 PM EST - Market closed

Embecta Revenue

In the fiscal year ending September 30, 2025, Embecta had annual revenue of $1.08B, down -3.80%. Embecta had revenue of $264.00M in the quarter ending September 30, 2025, a decrease of -7.72%.

Revenue (ttm)
$1.08B
Revenue Growth
-3.80%
P/S Ratio
0.59
Revenue / Employee
$584,000
Employees
1,850
Market Cap
647.78M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 20251.08B-42.70M-3.80%
Sep 30, 20241.12B2.30M0.21%
Sep 30, 20231.12B-8.70M-0.77%
Sep 30, 20221.13B-35.80M-3.07%
Sep 30, 20211.17B79.80M7.35%
Sep 30, 20201.09B-23.50M-2.12%
Sep 30, 20191.11B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Azenta593.82M
AtriCure518.31M
AngioDynamics307.31M
STAAR Surgical Company230.59M
BioLife Solutions100.14M
Kestra Medical Technologies74.26M
KORU Medical Systems39.07M
Anbio Biotechnology6.92M
Revenue Rankings

EMBC News

More News